4
Changes in Ownership
Axogen, Inc. Filed Acc 0000805928-21-000144
Chief R&D Officer gave up 637 shares (to pay taxes)
- Chief R&D Officer acquired 2,572 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Scopelianos Angelo Chief R&D Officer | 2021-07-19 | Grant or award | +2,572 | 10,757 | D: show line 1 in the form | ||
| Scopelianos Angelo Chief R&D Officer | 2021-07-20 | Shares withheld for taxes | −637 | $19.20 | $12,230 | 10,120 | D: show line 2 in the form |
Loading xslF345X03/wf-form4_162689844445878.xml…